{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T10:57:53Z","timestamp":1770116273083,"version":"3.49.0"},"reference-count":42,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"9","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Cosmet Laser Ther"],"published-print":{"date-parts":[[2025,3,3]]},"abstract":"<jats:sec>\n                    <jats:title>BACKGROUND<\/jats:title>\n                    <jats:p>\n                      Glioblastoma (GBM) is known for its significant intratumoral heterogeneity, making biopsies susceptible to underdiagnosis if samples are taken from less malignant regions. [\n                      <jats:sup>18<\/jats:sup>\n                      F]Fluciclovine, a novel PET tracer, has demonstrated high accumulation in glioma tissue, with minimal uptake in normal brain tissue.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>OBSERVATIONS<\/jats:title>\n                    <jats:p>\n                      A 50-year-old woman presented with sensory aphasia. MRI revealed a FLAIR lesion extending from the left parietal to the medial temporal lobe. [\n                      <jats:sup>18<\/jats:sup>\n                      F]Fluciclovine PET\/MRI identified two areas of increased uptake, both FLAIR negative. Stereotactic biopsy was used to obtain samples from PET-positive (PET+) and FLAIR-positive (FLAIR+) lesions. Pathological analysis of the PET+ lesion revealed densely proliferating tumor cells with irregularly enlarged nuclei, while the FLAIR+ lesion exhibited sparsely proliferating cells. Molecular analysis showed that both lesions were IDH wildtype with\n                      <jats:italic>MGMT<\/jats:italic>\n                      promoter hypomethylation. Sanger sequencing identified a telomerase reverse transcriptase promoter \u2212124 C&gt;T mutation in the PET+ lesion but not in the FLAIR+ lesion. The integrated diagnosis, based primarily on the PET+ lesion, was GBM, IDH wildtype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LESSONS<\/jats:title>\n                    <jats:p>\n                      This case highlights the importance of [\n                      <jats:sup>18<\/jats:sup>\n                      F]fluciclovine PET\/MRI in identifying high-cell-density regions, minimizing the risk of underdiagnosis in GBM. Further studies are necessary to evaluate its prognostic value in GBM management.\n                    <\/jats:p>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/thejns.org\/doi\/10.3171\/CASE24677\">https:\/\/thejns.org\/doi\/10.3171\/CASE24677<\/jats:ext-link>\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3171\/case24677","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T01:54:02Z","timestamp":1740966842000},"source":"Crossref","is-referenced-by-count":0,"title":["Utility of [18F]fluciclovine PET\/MRI for identifying the optimal biopsy target region, helping to avoid underdiagnosis in patients with glioblastoma: illustrative case"],"prefix":"10.3171","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7679-173X","authenticated-orcid":true,"given":"Daisuke","family":"Kawauchi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirokazu","family":"Sugino","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-6767","authenticated-orcid":true,"given":"Kimiteru","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaori","family":"Fuse","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4116-3370","authenticated-orcid":true,"given":"Yuko","family":"Kubo","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mai","family":"Honda-Kitahara","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yanagisawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-6582-7001","authenticated-orcid":true,"given":"Takaki","family":"Ohmura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9194-2623","authenticated-orcid":true,"given":"Takuma","family":"Aoki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiya","family":"Kawanishi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madoka","family":"Sakuramachi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7817-624X","authenticated-orcid":true,"given":"Hiroshi","family":"Igaki","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-6006","authenticated-orcid":true,"given":"Yoshitaka","family":"Narita","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery and Neuro-Oncology, National Cancer Center Hospital, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1754","reference":[{"issue":"8","key":"bib1","series-title":"Neuro Oncol","first-page":"1231","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","unstructured":"Louis DNPerry AWesseling PThe 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251."},{"issue":"10","key":"bib2","series-title":"Proc Natl Acad Sci U S A","first-page":"4009","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","unstructured":"Sottoriva ASpiteri IPiccirillo SGIntratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110(10):4009-4014."},{"issue":"14","key":"bib3","series-title":"Oncotarget","first-page":"12094","article-title":"From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity","volume":"6","author":"Aubry","year":"2015","unstructured":"Aubry Mde Tayrac MEtcheverry AFrom the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget. 2015;6(14):12094-12109."},{"issue":"5","key":"bib4","series-title":"J Nucl Med","first-page":"822","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","author":"Okudaira","year":"2011","unstructured":"Okudaira HShikano NNishii RPutative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med. 2011;52(5):822-829."},{"issue":"12","key":"bib5","series-title":"Cancer Sci","first-page":"2380","article-title":"l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms","volume":"99","author":"Kaira","year":"2008","unstructured":"Kaira KOriuchi NImai Hl-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci. 2008;99(12):2380-2386."},{"issue":"3","key":"bib6","series-title":"Mol Imaging Biol","first-page":"322","article-title":"Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose","volume":"16","author":"Oka","year":"2014","unstructured":"Oka SOkudaira HOno MDifferences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol. 2014;16(3):322-329."},{"issue":"2","key":"bib7","series-title":"J Nucl Med","first-page":"331","article-title":"Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors","volume":"40","author":"Shoup","year":"1999","unstructured":"Shoup TMOlson JHoffman JMSynthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med. 1999;40(2):331-338."},{"issue":"2","key":"bib8","series-title":"Asia Ocean J Nucl Med Biol","first-page":"85","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: A comparative study with L-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","unstructured":"Tsuyuguchi NTerakawa YUda TNakajo KKanemura Y.Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: A comparative study with L-methyl-11C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 2017;5(2):85-94."},{"issue":"1","key":"bib9","series-title":"Asia Ocean J Nucl Med Biol","first-page":"10","article-title":"Diagnostic performance and safety of positron emission tomography using 18F-Fluciclovine in patients with clinically suspected high- or low-grade gliomas: a multicenter Phase IIb trial","volume":"5","author":"Wakabayashi","year":"2017","unstructured":"Wakabayashi TIuchi TTsuyuguchi NDiagnostic performance and safety of positron emission tomography using 18F-Fluciclovine in patients with clinically suspected high- or low-grade gliomas: a multicenter Phase IIb trial. Asia Ocean J Nucl Med Biol. 2017;5(1):10-21."},{"issue":"5","key":"bib10","series-title":"Neurosurgery","first-page":"663","article-title":"What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas?","volume":"77","author":"Hadjipanayis","year":"2015","unstructured":"Hadjipanayis CGWidhalm GStummer W.What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery. 2015;77(5):663-673."},{"issue":"4","key":"bib11","series-title":"J Mol Diagn","first-page":"425","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","unstructured":"Tsiatis ACNorris-Kirby ARich RGComparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn.2010;12(4):425-432."},{"issue":"2","key":"bib12","series-title":"Neurosurgery","first-page":"160","article-title":"Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen","volume":"24","author":"Chandrasoma","year":"1989","unstructured":"Chandrasoma PTSmith MMApuzzo ML.Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery. 1989;24(2):160-165."},{"issue":"11","key":"bib13","series-title":"Neurology","first-page":"1741","article-title":"Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas","volume":"41","author":"Glantz","year":"1991","unstructured":"Glantz MJBurger PCHerndon JE2ndInfluence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology. 1991;41(11):1741-1744."},{"issue":"3","key":"bib14","series-title":"Neuro Oncol","first-page":"193","article-title":"Limitations of stereotactic biopsy in the initial management of gliomas","volume":"3","author":"Jackson","year":"2001","unstructured":"Jackson RJFuller GNAbi-Said DLimitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001;3(3):193-200."},{"issue":"4","key":"bib15","series-title":"Neurol Res","first-page":"358","article-title":"Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen","volume":"27","author":"Woodworth","year":"2005","unstructured":"Woodworth GMcGirt MJSamdani AGaronzik IOlivi AWeingart JD.Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res. 2005;27(4):358-362."},{"issue":"4","key":"bib16","series-title":"Cancer","first-page":"796","article-title":"Diagnostic discrepancies and their clinical impact in a neuropathology referral practice","volume":"79","author":"Bruner","year":"1997","unstructured":"Bruner JMInouye LFuller GNLangford LA.Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer. 1997;79(4):796-803."},{"issue":"4","key":"bib17","series-title":"Surg Neurol","first-page":"277","article-title":"MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen","volume":"59","author":"McGirt","year":"2003","unstructured":"McGirt MJVillavicencio ATBulsara KRFriedman AH.MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol. 2003;59(4):277-281."},{"issue":"10","key":"bib18","series-title":"Clin Neurol Neurosurg","first-page":"1955","article-title":"Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours","volume":"115","author":"Reithmeier","year":"2013","unstructured":"Reithmeier TLopez WODoostkam SIntraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours. Clin Neurol Neurosurg. 2013;115(10):1955-1960."},{"issue":"5","key":"bib19","series-title":"Neurosurgery","first-page":"741","article-title":"Early diagnosis and surgical intervention within 3 weeks from symptom onset are associated with prolonged survival of patients with glioblastoma","volume":"91","author":"Kawauchi","year":"2022","unstructured":"Kawauchi DOhno MMiyakita YEarly diagnosis and surgical intervention within 3 weeks from symptom onset are associated with prolonged survival of patients with glioblastoma. Neurosurgery. 2022;91(5):741-748."},{"issue":"12","key":"bib20","series-title":"Ann Nucl Med","first-page":"1279","article-title":"Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET\/CT in patients with suspected glioma: multicenter phase III trials","volume":"35","author":"Wakabayashi","year":"2021","unstructured":"Wakabayashi THirose YMiyake KDetermining the extent of tumor resection at surgical planning with 18F-fluciclovine PET\/CT in patients with suspected glioma: multicenter phase III trials. Ann Nucl Med. 2021;35(12):1279-1292."},{"issue":"2","key":"bib21","series-title":"Neurooncol Pract","first-page":"152","article-title":"18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling","volume":"7","author":"Henderson","year":"2020","unstructured":"Henderson FJrBrem SO\u2019Rourke DM18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling. Neurooncol Pract. 2020;7(2):152-157."},{"issue":"8","key":"bib1","series-title":"Neuro Oncol","first-page":"1231","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","unstructured":"Louis DNPerry AWesseling PThe 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231-1251."},{"issue":"10","key":"bib2","series-title":"Proc Natl Acad Sci U S A","first-page":"4009","article-title":"Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics","volume":"110","author":"Sottoriva","year":"2013","unstructured":"Sottoriva ASpiteri IPiccirillo SGIntratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci U S A. 2013;110(10):4009-4014."},{"issue":"14","key":"bib3","series-title":"Oncotarget","first-page":"12094","article-title":"From the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity","volume":"6","author":"Aubry","year":"2015","unstructured":"Aubry Mde Tayrac MEtcheverry AFrom the core to beyond the margin: a genomic picture of glioblastoma intratumor heterogeneity. Oncotarget. 2015;6(14):12094-12109."},{"issue":"5","key":"bib4","series-title":"J Nucl Med","first-page":"822","article-title":"Putative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer","volume":"52","author":"Okudaira","year":"2011","unstructured":"Okudaira HShikano NNishii RPutative transport mechanism and intracellular fate of trans-1-amino-3-18F-fluorocyclobutanecarboxylic acid in human prostate cancer. J Nucl Med. 2011;52(5):822-829."},{"issue":"12","key":"bib5","series-title":"Cancer Sci","first-page":"2380","article-title":"l-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms","volume":"99","author":"Kaira","year":"2008","unstructured":"Kaira KOriuchi NImai Hl-type amino acid transporter 1 and CD98 expression in primary and metastatic sites of human neoplasms. Cancer Sci. 2008;99(12):2380-2386."},{"issue":"3","key":"bib6","series-title":"Mol Imaging Biol","first-page":"322","article-title":"Differences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose","volume":"16","author":"Oka","year":"2014","unstructured":"Oka SOkudaira HOno MDifferences in transport mechanisms of trans-1-amino-3-[18F]fluorocyclobutanecarboxylic acid in inflammation, prostate cancer, and glioma cells: comparison with L-[methyl-11C]methionine and 2-deoxy-2-[18F]fluoro-D-glucose. Mol Imaging Biol. 2014;16(3):322-329."},{"issue":"2","key":"bib7","series-title":"J Nucl Med","first-page":"331","article-title":"Synthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors","volume":"40","author":"Shoup","year":"1999","unstructured":"Shoup TMOlson JHoffman JMSynthesis and evaluation of [18F]1-amino-3-fluorocyclobutane-1-carboxylic acid to image brain tumors. J Nucl Med. 1999;40(2):331-338."},{"issue":"2","key":"bib8","series-title":"Asia Ocean J Nucl Med Biol","first-page":"85","article-title":"Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: A comparative study with L-methyl-11C-methionine PET imaging","volume":"5","author":"Tsuyuguchi","year":"2017","unstructured":"Tsuyuguchi NTerakawa YUda TNakajo KKanemura Y.Diagnosis of brain tumors using amino acid transport PET imaging with 18F-fluciclovine: A comparative study with L-methyl-11C-methionine PET imaging. Asia Ocean J Nucl Med Biol. 2017;5(2):85-94."},{"issue":"1","key":"bib9","series-title":"Asia Ocean J Nucl Med Biol","first-page":"10","article-title":"Diagnostic performance and safety of positron emission tomography using 18F-Fluciclovine in patients with clinically suspected high- or low-grade gliomas: a multicenter Phase IIb trial","volume":"5","author":"Wakabayashi","year":"2017","unstructured":"Wakabayashi TIuchi TTsuyuguchi NDiagnostic performance and safety of positron emission tomography using 18F-Fluciclovine in patients with clinically suspected high- or low-grade gliomas: a multicenter Phase IIb trial. Asia Ocean J Nucl Med Biol. 2017;5(1):10-21."},{"issue":"5","key":"bib10","series-title":"Neurosurgery","first-page":"663","article-title":"What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas?","volume":"77","author":"Hadjipanayis","year":"2015","unstructured":"Hadjipanayis CGWidhalm GStummer W.What is the surgical benefit of utilizing 5-aminolevulinic acid for fluorescence-guided surgery of malignant gliomas? Neurosurgery. 2015;77(5):663-673."},{"issue":"4","key":"bib11","series-title":"J Mol Diagn","first-page":"425","article-title":"Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications","volume":"12","author":"Tsiatis","year":"2010","unstructured":"Tsiatis ACNorris-Kirby ARich RGComparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn.2010;12(4):425-432."},{"issue":"2","key":"bib12","series-title":"Neurosurgery","first-page":"160","article-title":"Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen","volume":"24","author":"Chandrasoma","year":"1989","unstructured":"Chandrasoma PTSmith MMApuzzo ML.Stereotactic biopsy in the diagnosis of brain masses: comparison of results of biopsy and resected surgical specimen. Neurosurgery. 1989;24(2):160-165."},{"issue":"11","key":"bib13","series-title":"Neurology","first-page":"1741","article-title":"Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas","volume":"41","author":"Glantz","year":"1991","unstructured":"Glantz MJBurger PCHerndon JE2ndInfluence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology. 1991;41(11):1741-1744."},{"issue":"3","key":"bib14","series-title":"Neuro Oncol","first-page":"193","article-title":"Limitations of stereotactic biopsy in the initial management of gliomas","volume":"3","author":"Jackson","year":"2001","unstructured":"Jackson RJFuller GNAbi-Said DLimitations of stereotactic biopsy in the initial management of gliomas. Neuro Oncol. 2001;3(3):193-200."},{"issue":"4","key":"bib15","series-title":"Neurol Res","first-page":"358","article-title":"Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen","volume":"27","author":"Woodworth","year":"2005","unstructured":"Woodworth GMcGirt MJSamdani AGaronzik IOlivi AWeingart JD.Accuracy of frameless and frame-based image-guided stereotactic brain biopsy in the diagnosis of glioma: comparison of biopsy and open resection specimen. Neurol Res. 2005;27(4):358-362."},{"issue":"4","key":"bib16","series-title":"Cancer","first-page":"796","article-title":"Diagnostic discrepancies and their clinical impact in a neuropathology referral practice","volume":"79","author":"Bruner","year":"1997","unstructured":"Bruner JMInouye LFuller GNLangford LA.Diagnostic discrepancies and their clinical impact in a neuropathology referral practice. Cancer. 1997;79(4):796-803."},{"issue":"4","key":"bib17","series-title":"Surg Neurol","first-page":"277","article-title":"MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen","volume":"59","author":"McGirt","year":"2003","unstructured":"McGirt MJVillavicencio ATBulsara KRFriedman AH.MRI-guided stereotactic biopsy in the diagnosis of glioma: comparison of biopsy and surgical resection specimen. Surg Neurol. 2003;59(4):277-281."},{"issue":"10","key":"bib18","series-title":"Clin Neurol Neurosurg","first-page":"1955","article-title":"Intraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours","volume":"115","author":"Reithmeier","year":"2013","unstructured":"Reithmeier TLopez WODoostkam SIntraindividual comparison of histopathological diagnosis obtained by stereotactic serial biopsy to open surgical resection specimen in patients with intracranial tumours. Clin Neurol Neurosurg. 2013;115(10):1955-1960."},{"issue":"5","key":"bib19","series-title":"Neurosurgery","first-page":"741","article-title":"Early diagnosis and surgical intervention within 3 weeks from symptom onset are associated with prolonged survival of patients with glioblastoma","volume":"91","author":"Kawauchi","year":"2022","unstructured":"Kawauchi DOhno MMiyakita YEarly diagnosis and surgical intervention within 3 weeks from symptom onset are associated with prolonged survival of patients with glioblastoma. Neurosurgery. 2022;91(5):741-748."},{"issue":"12","key":"bib20","series-title":"Ann Nucl Med","first-page":"1279","article-title":"Determining the extent of tumor resection at surgical planning with 18F-fluciclovine PET\/CT in patients with suspected glioma: multicenter phase III trials","volume":"35","author":"Wakabayashi","year":"2021","unstructured":"Wakabayashi THirose YMiyake KDetermining the extent of tumor resection at surgical planning with 18F-fluciclovine PET\/CT in patients with suspected glioma: multicenter phase III trials. Ann Nucl Med. 2021;35(12):1279-1292."},{"issue":"2","key":"bib21","series-title":"Neurooncol Pract","first-page":"152","article-title":"18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling","volume":"7","author":"Henderson","year":"2020","unstructured":"Henderson FJrBrem SO\u2019Rourke DM18F-Fluciclovine PET to distinguish treatment-related effects from disease progression in recurrent glioblastoma: PET fusion with MRI guides neurosurgical sampling. Neurooncol Pract. 2020;7(2):152-157."}],"container-title":["Journal of Neurosurgery: Case Lessons"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/9\/9\/article-CASE24677.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/9\/9\/article-CASE24677.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg-case-lessons\/9\/9\/article-CASE24677.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T23:37:54Z","timestamp":1770075474000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg-case-lessons\/9\/9\/article-CASE24677.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":42,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.3171\/case24677","relation":{},"ISSN":["2694-1902"],"issn-type":[{"value":"2694-1902","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]}}}